News

Out of an abundance of caution, CDC is taking aggressive steps to protect the health of all involved, including providing protective courses of antibiotics for potentially exposed staff.

The ceftolozane/tazobactam is being developed to treat complicated urinary tract and intra-abdominal infections. The submission of NDA is supported by the positive data from two pivotal Phase 3

The decision was taken as the studies showed that orteronel plus prednisone could extend the time patients lived before their cancer progressed but failed to extend overall survival

The patent, entitled Chemically Modified Ligase Cofactors, Donors, and Acceptors, is directed toward the use of modified ligation components to improve fidelity in nucleic acid ligation. The research

The new platform will be based on Akrivis Technologies’ proprietary Z-TECT technology that targets and detects unusually low levels of proteins and molecular targets and Leti’s Lipidot nanovector

Cellectis said that its CAR-T technology offers an allogeneic approach in developing CAR-T therapies that are distinct from other autologous approaches. As part of the deal, Pfizer will

VX-787 is an influenza A-specific, oral polymerase inhibitor designed to directly inhibit replication of the influenza A virus, including recent H1 and H5 influenza strains, based on in-vitro

Under the deal, Medison will market Glybera, uniQure’s gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority. Medison will also

Under the deal, Cipher has granted Andrómaco the exclusive right to market, sell and distribute its isotretinoin capsules in the country. After securing regulatory approval, it is expected